CSL Limited

CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications.

The company was established in 19161 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994.

Acquisition history

CSL Limited (Founded 1916 as Commonwealth Serum Laboratories) ZLB Behring ZLB Bioplasma AG (Acq 2000) Aventis Behring (Acq 2004) Vifor Pharma (Acq 2021) Seqirus (Merged 2014) BioCSL Novartis Influenza Vaccines div. Calimmune (Acq 2017) Vitaeris (Acq 2020)

Text derived from https://en.wikipedia.org/w/index.php?oldid=1373230115 under CC BY-SA 4.0; modifications have been made.

References

  1. ↩Wikipedia “CSL Limited” revision 1373230115 · retrieved 2026-10-20 date of establishment (×2) · confidence 0.95 revision URL